Deletion ofAbcg2Has Differential Effects on Excretion and Pharmacokinetics of Probe Substrates in Rats-Reference-Cited by-同舟云学术

Deletion ofAbcg2Has Differential Effects on Excretion and Pharmacokinetics of Probe Substrates in Rats

Published:2012-08-06 Issue:2 Volume:343 Page:316-324
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Huang Liyue,Be Xuhai,Tchaparian Eskouhie H.,Colletti Adria E.,Roberts Jonathan,Langley Meghan,Ling Yun,Wong Bradley K.,Jin Lixia

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference44 articles.

1. Oral sulfasalazine as a clinical BCRP probe substrate: pharmacokinetic effects of genetic variation (C421A) and pantoprazole coadministration;Adkison;J Pharm Sci,2010

2. TheABCG2C421A polymorphism does not affect oral nitrofurantoin pharmacokinetics in healthy Chinese male subjects

3. Effect of androgen administration during puberty on hepatic CYP2C11, CYP3A, and CYP2A1 expression in adult female rats;Anderson;Drug Metab Dispos,1998

4. BDDCS Applied to Over 900 Drugs

5. Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: A resource for investigations into drug disposition

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a Physiologically Based Pharmacokinetic Model for Nitrofurantoin in Rabbits, Rats, and Humans;Pharmaceutics;2023-08-25

2. Adeno-associated virus-mediated knockdown demonstrates the major role of hepatic Bcrp in the overall disposition of the active metabolite of the tyrosine kinase inhibitor regorafenib in mice;Drug Metabolism and Pharmacokinetics;2023-04

3. Regulation of BCRP expression and sulfasalazine pharmacokinetics by the nuclear receptor REV-ERBα;Xenobiotica;2023-03-04

4. Physiologically based pharmacokinetic model to predict drug concentrations of breast cancer resistance protein substrates in milk;Biopharmaceutics & Drug Disposition;2022-11-02

5. Simple and efficient one-pot multi-step strategy for the synthesis of 2-substituted (1,2,5-triarylpyrrolo[3,2-c]pyridin-3-yl)-N-arylacetamide derivatives in water;Organic & Biomolecular Chemistry;2021